Nigel Gilligan
Geschäftsführer bei TRAJAN GROUP HOLDINGS LIMITED
Vermögen: 45 321 $ am 30.04.2024
Profil
Nigel Gilligan is currently the Chief Operations Officer at Trajan Scientific & Medical Pty Ltd.
and Trajan Group Holdings Ltd.
He previously worked as the Director-EMEA Operations & General Manager at Hospira, Inc. and as the Head-APAC Supply Chain at Mayne Pharma Ltd.
Mr. Gilligan completed his undergraduate degree at Monash University.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
30.06.2023 | 65 229 ( 0,04% ) | 45 321 $ | 30.04.2024 |
Aktive Positionen von Nigel Gilligan
Unternehmen | Position | Beginn |
---|---|---|
TRAJAN GROUP HOLDINGS LIMITED | Geschäftsführer | - |
Trajan Scientific & Medical Pty Ltd.
Trajan Scientific & Medical Pty Ltd. Medical SpecialtiesHealth Technology Trajan Scientific & Medical Pty Ltd. designs, manufactures and markets scientific and medical devices. The firm focuses on developing and commercializing technologies that enable analytical systems to be specific for biological, environmental or food related measurements. The company was founded in 2011 and is headquartered in Ringwood, Australia. | Geschäftsführer | - |
Ehemalige bekannte Positionen von Nigel Gilligan
Unternehmen | Position | Ende |
---|---|---|
Mayne Pharma Ltd.
Mayne Pharma Ltd. Pharmaceuticals: OtherHealth Technology Mayne Pharma Ltd. manufactures pharmaceutical products. It distributes generic injectables for the oncology market. The company's competitors include Sandoz, Bedford Labs, and Ebewe. It was founded in November 2005 and is headquartered in Melbourne, Australia. | Corporate Officer/Principal | - |
HOSPIRA, INC. | Corporate Officer/Principal | - |
Ausbildung von Nigel Gilligan
Monash University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
TRAJAN GROUP HOLDINGS LIMITED | Commercial Services |
Private Unternehmen | 3 |
---|---|
Hospira, Inc.
Hospira, Inc. Pharmaceuticals: MajorHealth Technology Hospira, Inc. provides injectable drugs and infusion technologies. It offers drugs, IV sets and clinical integration, infusion pumps, clinical software and implementation services. The company was founded on September 16, 2003 and is headquartered in Lake Forest, IL. | Health Technology |
Mayne Pharma Ltd.
Mayne Pharma Ltd. Pharmaceuticals: OtherHealth Technology Mayne Pharma Ltd. manufactures pharmaceutical products. It distributes generic injectables for the oncology market. The company's competitors include Sandoz, Bedford Labs, and Ebewe. It was founded in November 2005 and is headquartered in Melbourne, Australia. | Health Technology |
Trajan Scientific & Medical Pty Ltd.
Trajan Scientific & Medical Pty Ltd. Medical SpecialtiesHealth Technology Trajan Scientific & Medical Pty Ltd. designs, manufactures and markets scientific and medical devices. The firm focuses on developing and commercializing technologies that enable analytical systems to be specific for biological, environmental or food related measurements. The company was founded in 2011 and is headquartered in Ringwood, Australia. | Health Technology |